{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:58:11Z","timestamp":1789379891664,"version":"build-2803163510"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T00:00:00Z","timestamp":1415145600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0112327","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T19:27:39Z","timestamp":1415215659000},"page":"e112327","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":70,"title":["Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury"],"prefix":"10.1371","volume":"9","author":[{"given":"Alexander","family":"Wehr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Baeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Gassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanishka","family":"Hittatiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf Peter","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,11,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jgh.12212","article-title":"Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches","volume":"28","author":"D Schuppan","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"M Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.2174\/13816128113199990336","article-title":"Epidemiology and natural history of patients with NAFLD","volume":"19","author":"N Bhala","year":"2013","journal-title":"Curr Pharm Des"},{"key":"ref4","first-page":"2101","article-title":"Prognosis of patients with a diagnosis of fatty liver\u2013a registry-based cohort study","volume":"50","author":"P Jepsen","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/SLA.0b013e31826b4b7e","article-title":"Liver transplantation for nonalcoholic steatohepatitis: the new epidemic","volume":"256","author":"VG Agopian","year":"2012","journal-title":"Ann Surg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.2174\/13816128113199990344","article-title":"Pathophysiology of NASH: perspectives for a targeted treatment","volume":"19","author":"F Marra","year":"2013","journal-title":"Curr Pharm Des"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"CK Argo","year":"2009","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Marra F, Tacke F (2014) Roles for Chemokines in Liver Disease. Gastroenterology 147: 577\u2013594 e571.","DOI":"10.1053\/j.gastro.2014.06.043"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.4049\/jimmunol.1202909","article-title":"Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis","volume":"190","author":"A Wehr","year":"2013","journal-title":"J Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri1309","article-title":"NKT cells: what\u2019s in a name?","volume":"4","author":"DI Godfrey","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/liv.12182","article-title":"The regulation of T-cell recruitment to the human liver during acute liver failure","volume":"33","author":"C Tuncer","year":"2013","journal-title":"Liver Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0168-8278(02)00328-8","article-title":"Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes","volume":"38","author":"J Boisvert","year":"2003","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1371\/journal.pbio.0030113","article-title":"Intravascular immune surveillance by CXCR6<sup>+<\/sup> NKT cells patrolling liver sinusoids","volume":"3","author":"F Geissmann","year":"2005","journal-title":"PLoS Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e11049","DOI":"10.1371\/journal.pone.0011049","article-title":"Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis","volume":"5","author":"HW Zimmermann","year":"2010","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"DE Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"ref16","first-page":"855","article-title":"Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications","volume":"79","author":"MJ Mattes","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"ref17","first-page":"187","article-title":"The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage","volume":"26","author":"RL Wahl","year":"1988","journal-title":"Cancer Immunol Immunother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00311341","article-title":"Biodistribution of radiolabeled monoclonal antibody after intraperitoneal administration in nude mice with hepatic metastasis from human colon cancer","volume":"22","author":"K Yoshida","year":"1992","journal-title":"Surg Today"},{"key":"ref19","first-page":"3434","article-title":"Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat","volume":"51","author":"JS Barrett","year":"1991","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/hep.22264","article-title":"Hepatocyte-specific inhibitor-of-kappaB-kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration","volume":"47","author":"Y Malato","year":"2008","journal-title":"Hepatology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/187152811798104890","article-title":"Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis","volume":"10","author":"HW Zimmermann","year":"2011","journal-title":"Inflamm Allergy Drug Targets"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.26697","article-title":"Chemokine receptor CCR6-dependent accumulation of gammadelta T-cells in injured liver restricts hepatic inflammation and fibrosis","volume":"59","author":"L Hammerich","year":"2014","journal-title":"Hepatology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.22950","article-title":"Hepatic recruitment of the inflammatory Gr1<sup>+<\/sup> monocyte subset upon liver injury promotes hepatic fibrosis","volume":"50","author":"KR Karlmark","year":"2009","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00428-011-1066-1","article-title":"Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease","volume":"458","author":"A Tannapfel","year":"2011","journal-title":"Virchows Arch"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"C Baeck","year":"2012","journal-title":"Gut"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.22813","article-title":"Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride","volume":"49","author":"O Park","year":"2009","journal-title":"Hepatology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","article-title":"Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace","volume":"56","author":"G Baffy","year":"2012","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4049\/jimmunol.181.1.81","article-title":"Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells","volume":"181","author":"E Germanov","year":"2008","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.immunol.25.022106.141711","article-title":"The biology of NKT cells","volume":"25","author":"A Bendelac","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.4049\/jimmunol.179.12.8172","article-title":"Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells","volume":"179","author":"T Shimaoka","year":"2007","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.3748\/wjg.v11.i32.4979","article-title":"CXCL16 participates in pathogenesis of immunological liver injury by regulating T lymphocyte infiltration in liver tissue","volume":"11","author":"HB Xu","year":"2005","journal-title":"World J Gastroenterol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2010.221879","article-title":"SR-PSOX\/CXCL16 plays a critical role in the progression of colonic inflammation","volume":"60","author":"N Uza","year":"2011","journal-title":"Gut"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/CS20110515","article-title":"Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis","volume":"123","author":"S Galastri","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/gutjnl-2011-301857","article-title":"NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease","volume":"61","author":"WK Syn","year":"2012","journal-title":"Gut"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jhep.2010.08.022","article-title":"CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice","volume":"54","author":"S Ishikawa","year":"2011","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23983","article-title":"Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells","volume":"53","author":"Z Jin","year":"2011","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/hep.23599","article-title":"Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease","volume":"51","author":"WK Syn","year":"2010","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Wang H, Feng D, Park O, Yin S, Gao B (2013) Invariant NKT cell activation induces neutrophil accumulation and hepatitis: Oppositely regulated by IL-4 and IFN-gamma. Hepatology.","DOI":"10.1002\/hep.26471"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2353\/ajpath.2009.080960","article-title":"CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein","volume":"174","author":"P Gutwein","year":"2009","journal-title":"Am J Pathol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1111\/j.1582-4934.2009.00761.x","article-title":"CXCL16 and oxLDL are induced in the onset of diabetic nephropathy","volume":"13","author":"P Gutwein","year":"2009","journal-title":"J Cell Mol Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1582-4934.2008.00223.x","article-title":"Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6<sup>+<\/sup> lymphocyte recruitment in vitro and in vivo","volume":"12","author":"O Postea","year":"2008","journal-title":"J Cell Mol Med"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-0032-1330422","article-title":"Liver fibrosis - mouse models and relevance in human liver diseases","volume":"51","author":"I Mederacke","year":"2013","journal-title":"Z Gastroenterol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1186\/1755-1536-5-S1-S27","article-title":"Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo","volume":"5","author":"F Tacke","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e92515","DOI":"10.1371\/journal.pone.0092515","article-title":"Involvement of the TNF and FasL produced by CD11b Kupffer cells\/macrophages in CCl4-induced acute hepatic injury","volume":"9","author":"A Sato","year":"2014","journal-title":"PLoS One"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0112327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T14:55:20Z","timestamp":1747148120000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0112327"}},"subtitle":[],"editor":[{"given":"Anna","family":"Alisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,11,5]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2014,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0112327","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,5]]}}}